Logo image of GRDN

GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Fundamental Analysis

NYSE:GRDN - New York Stock Exchange, Inc. - US40145W1018 - Common Stock - Currency: USD

20.33  -0.57 (-2.73%)

After market: 20.33 0 (0%)

Fundamental Rating

4

Overall GRDN gets a fundamental rating of 4 out of 10. We evaluated GRDN against 40 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of GRDN is average, but there are quite some concerns on its profitability. GRDN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

GRDN had negative earnings in the past year.
Of the past 5 years GRDN 4 years were profitable.
GRDN had a positive operating cash flow in each of the past 5 years.
GRDN Yearly Net Income VS EBIT VS OCF VS FCFGRDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

GRDN's Return On Assets of -30.63% is on the low side compared to the rest of the industry. GRDN is outperformed by 90.00% of its industry peers.
Looking at the Return On Equity, with a value of -65.54%, GRDN is doing worse than 82.50% of the companies in the same industry.
Industry RankSector Rank
ROA -30.63%
ROE -65.54%
ROIC N/A
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
GRDN Yearly ROA, ROE, ROICGRDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

GRDN has a Gross Margin of 19.68%. This is in the lower half of the industry: GRDN underperforms 60.00% of its industry peers.
GRDN's Gross Margin has been stable in the last couple of years.
GRDN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
GRDN Yearly Profit, Operating, Gross MarginsGRDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

GRDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GRDN has more shares outstanding
The number of shares outstanding for GRDN has been increased compared to 5 years ago.
Compared to 1 year ago, GRDN has an improved debt to assets ratio.
GRDN Yearly Shares OutstandingGRDN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GRDN Yearly Total Debt VS Total AssetsGRDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 7.89 indicates that GRDN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.89, GRDN belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
GRDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.89
ROIC/WACCN/A
WACC8.9%
GRDN Yearly LT Debt VS Equity VS FCFGRDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 50M 100M

2.3 Liquidity

A Current Ratio of 1.14 indicates that GRDN should not have too much problems paying its short term obligations.
GRDN's Current ratio of 1.14 is in line compared to the rest of the industry. GRDN outperforms 55.00% of its industry peers.
GRDN has a Quick Ratio of 1.14. This is a bad value and indicates that GRDN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.84, GRDN is doing good in the industry, outperforming 72.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.84
GRDN Yearly Current Assets VS Current LiabilitesGRDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for GRDN have decreased strongly by -567.05% in the last year.
The Revenue has grown by 17.42% in the past year. This is quite good.
GRDN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.96% yearly.
EPS 1Y (TTM)-567.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400.67%
Revenue 1Y (TTM)17.42%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%32.28%

3.2 Future

Based on estimates for the next years, GRDN will show a very strong growth in Earnings Per Share. The EPS will grow by 42.06% on average per year.
Based on estimates for the next years, GRDN will show a small growth in Revenue. The Revenue will grow by 7.33% on average per year.
EPS Next Y160%
EPS Next 2Y67.08%
EPS Next 3Y42.06%
EPS Next 5YN/A
Revenue Next Year10.26%
Revenue Next 2Y6.15%
Revenue Next 3Y7.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GRDN Yearly Revenue VS EstimatesGRDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
GRDN Yearly EPS VS EstimatesGRDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.5 -0.5 1 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

GRDN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 20.98, which indicates a rather expensive current valuation of GRDN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GRDN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of GRDN to the average of the S&P500 Index (36.21), we can say GRDN is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 20.98
GRDN Price Earnings VS Forward Price EarningsGRDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRDN Per share dataGRDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

GRDN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GRDN's earnings are expected to grow with 42.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y67.08%
EPS Next 3Y42.06%

More info and screens

0

5. Dividend

5.1 Amount

GRDN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GUARDIAN PHRMCY SERVICES-A

NYSE:GRDN (8/1/2025, 8:04:01 PM)

After market: 20.33 0 (0%)

20.33

-0.57 (-2.73%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-11 2025-08-11
Inst Owners42.2%
Inst Owner Change0.88%
Ins Owners3.92%
Ins Owner Change-116.37%
Market Cap1.29B
Analysts84.44
Price Target27.88 (37.14%)
Short Float %3.01%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.7%
Min EPS beat(2)-18.3%
Max EPS beat(2)12.89%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.13%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)0.51%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.38%
PT rev (3m)9.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-18.42%
EPS NY rev (1m)-1.37%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20.98
P/S 0.98
P/FCF N/A
P/OCF N/A
P/B 8.24
P/tB 17.7
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)0.97
Fwd EY4.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS20.68
BVpS2.47
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.63%
ROE -65.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.68%
FCFM N/A
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
F-ScoreN/A
Asset Turnover3.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.84
Altman-Z 7.89
F-ScoreN/A
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)87.95%
Cap/Depr(5y)73.67%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-567.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400.67%
EPS Next Y160%
EPS Next 2Y67.08%
EPS Next 3Y42.06%
EPS Next 5YN/A
Revenue 1Y (TTM)17.42%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%32.28%
Revenue Next Year10.26%
Revenue Next 2Y6.15%
Revenue Next 3Y7.33%
Revenue Next 5YN/A
EBIT growth 1Y-253.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-5.46%
FCF growth 5Y-0.01%
OCF growth 1Y-18.16%
OCF growth 3Y-0.31%
OCF growth 5Y0.63%